Hidalgo, Manuel; Amant, Frederic; Biankin, Andrew V.; Budinská, Eva; Byrne, Annette T.; Caldas, Carlos; 等人 (2014):患者来源的异种移植模型:一种新兴的癌症转化研究平台。爱尔兰皇家外科医学院。期刊投稿。https://hdl.handle.net/10779/rcsi.10793177.v1
J Cummings has provided consultation to Acadia, Alkahest, AlphaCognition, AriBio, Biogen, Cassava, Cortexyme, Diadem, EIP Pharma, Eisai, GemVax, Genentech, Green Valley, Grifols, Janssen, Karuna, Lilly, LSP, Merck, NervGen, Novo Nordisk A/S, Oligomerix, Ono, Otsuka,Prodeo,Prothena,Remynd,Resverlogix,Roche,Cignant Health,Suven和United Neuroscience Pharmaceutical,评估和投资公司。他得到了美国国家一般医学科学研究所(NIGMS)的支持。国家神经系统疾病与中风研究所(NINDS)授予U01NS093334;国家老化研究所(NIA)赠款R01AG053798,P20AG068053,P30AG072959和R35AG71476;阿尔茨海默氏病药物发现基金会(ADDF);泰德(Ted)和玛丽亚·奎克(Maria Quirk)的捐赠;以及欢乐钱伯斯·瑞迪的捐赠。G Grossberg已向Acadia,Alkahest,Avanir,Axovant,Axsome Therapeutics,Biogen,Bioxcel,Gioxcel,Genentech,Karuna,Lundbeck,Otsuka,Roche,Roche和Takeda提供了咨询。他为礼来,罗氏和美国国家衰老研究所提供了研究支持。他曾在Acadia,Biogen和Eisai的发言人局任职,并曾在Anavex,Erydel,Elydarlulartherapies,Merck,Newron,Newron和Doligomerix的安全监测委员会任职。A.P. Porsteinsson报告了Acadia Pharmaceuticals,Athira,Biogen,BMS,认知研究公司,EISAI,功能性神经调节,IQVIA,IQVIA,Lundbeck,Novartis,Ono Pharmaceuticals,Otsuka,Otsuka,WebMD和Xenon;从Alector,Athira,Biogen,Cassava,Eisai,Eli Lilly,Genentech/Roche,Roche,Vaccinex,Nia,Nia,Nimh和Dod授予他的机构。A.P.Porsteinsson报告了Acadia Pharmaceuticals,Athira,Biogen,BMS,认知研究公司,EISAI,功能性神经调节,IQVIA,IQVIA,Lundbeck,Novartis,Ono Pharmaceuticals,Otsuka,Otsuka,WebMD和Xenon;从Alector,Athira,Biogen,Cassava,Eisai,Eli Lilly,Genentech/Roche,Roche,Vaccinex,Nia,Nia,Nimh和Dod授予他的机构。